VISIT CONTRACT PHARMA AT #1115

Novel Surfactant Excipient Improves Biologic Stability in Liquid Formulation

11.13.19

Joshua Katz of Dupont discusses his work involving new excipients for the biopharmaceutical space

Joshua Katz, Senior Principal Scientist, Pharma Solutions at Dupont discusses his work involving new excipients for the biopharmaceutical space. Dupont has developed a surfactant technology that addresses many of the limitations of currently available technologies on the market.